Which company does Spasentan/Sparsentan come from?

Sparsentan is a drug discovered and developed by Pharmacopeia, Inc., originally named PS433540. This drug belongs to the dual-action receptor antagonist (DARA) class and is used to treat hypertension and diabetic nephropathy. After Ligand Pharmaceuticals acquired Pharmacopeia, the DARA program was licensed to Retrophin and developed into RES-021 in 2012. Over time, Retrophin changed its name to Travere Therapeutics, continuing the development of sparsentin.

Sparsentan is an innovative treatment specifically for adults with primary immunoglobulinA nephropathy (IgAN), a disease that causes the kidneys to progressively lose function. IgAN usually manifests as increased protein levels in the urine, which may lead to the patient ultimately needing dialysis or a kidney transplant. This drug is particularly suitable for patients whose urine contains at least 1 gram of protein per day or whose urine protein/creatinine ratio is at least 0.75 g/g. By selectively antagonizing specific receptors associated with kidney disease, sparsantane is designed to reduce kidney inflammation and fibrosis, thereby slowing disease progression.

Clinical studies of sparsentan have shown that the drug has significant effects in reducing urinary protein levels and improving kidney function, especially in IgAN patients. These findings have the potential to treat such diseases and provide new hope for patients. Due to the complexity and individual variability of IgAN, the efficacy and safety of sparsentane are being further evaluated to ensure that patients receive the best possible treatment outcome.

In addition, the development of sparsentan reflects the trend in modern drug development to focus on treatments that target specific disease mechanisms. As the understanding of the pathophysiology of kidney disease deepens, new drugs such as sparsentane are receiving increasing attention and can provide patients with more precise and effective treatment options.

Reference materials:https://en.wikipedia.org/wiki/Sparsentan